🇺🇸 depakine chrono in United States
1,494 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 1,494
Most-reported reactions
- Epilepsy — 342 reports (22.89%)
- Foetal Exposure During Pregnancy — 270 reports (18.07%)
- Somnolence — 163 reports (10.91%)
- Loss Of Consciousness — 123 reports (8.23%)
- Dysmorphism — 113 reports (7.56%)
- Disturbance In Attention — 102 reports (6.83%)
- Tremor — 101 reports (6.76%)
- Fall — 97 reports (6.49%)
- Confusional State — 93 reports (6.22%)
- Suicide Attempt — 90 reports (6.02%)
Other Neurology / Psychiatry approved in United States
Frequently asked questions
Is depakine chrono approved in United States?
depakine chrono does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for depakine chrono in United States?
Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.